The 12-month consensus price target is at $104.68. Pacira posted its Q2 earning July 31, reporting revenue of $47.2 million
More articles on Pacira Pharmaceuticals:
Pacira’s EXPAREL sales at $44.9M for Q2
Pacira Joins NPSF Coalition
Study: EXPAREL Infiltration Effectively Controls Postsurgical Pain
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
